Posts

Showing posts with the label HTA

GLP-1s and the Rise of Consumer-Led Pharma: What the Obesity Market Signals for the Future of Access

Access To The New Alzheimer's Drugs: Why HTA Bodies Are Saying No

Taking on the access hurdles for orphan drugs: preparing for EU HTA

EU HTA is now live: what do we do now?

Changes in Market Access in Europe and Implications for Clinical Development Planning: Joint Clinical Assessments